Item 2(b) is hereby amended and restated to read as follows: The principal business address of each of the Reporting Persons is 222 S Riverside Plaza, 15th Floor, Chicago, Illinois 60606.

Item 2(c) is hereby amended and restated to read as follows: The principal business of each of Stoney Lonesome and Drake Helix is investing in securities. The principal business of CCM is serving as the general partner of Stoney Lonesome. The principal business of CDC Financial is serving as the managing member of each of CCM and Drake Helix. The principal occupation of Mr. Coghill is serving as the President and sole shareholder of CDC Financial.

Item 2(d) is hereby amended and restated to read as follows: No Reporting Person, nor any person listed on Exhibit 1, has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

Item 2(e) is hereby amended and restated to read as follows: No Reporting Person, nor any person listed on Exhibit 1, has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 2(f) is hereby amended and restated to read as follows: Each of Stoney Lonesome and CCM is organized under the laws of the State of Delaware. Drake Helix is organized under the laws of the State of Wyoming. CDC Financial is organized under the laws of the State of Illinois. Mr. Coghill is a citizen of the United States of America.

Item 3 is hereby amended and restated to read as follows: The Shares purchased by Stoney Lonesome and Drake Helix were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 3,504,347 Shares directly owned by Stoney Lonesome is approximately $19,653,735, including brokerage commissions. The aggregate purchase price of the 83,000 Shares directly owned by Drake Helix is approximately $519,357, including brokerage commissions. The Shares directly owned by Mr. Coghill were purchased with personal funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 2,410 Shares directly owned by Mr. Coghill is approximately $16,750, including brokerage commissions.

Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based on 40,466,053 Shares outstanding as of August 1, 2025, which is the total number of Shares outstanding as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2025. As of the date hereof, Stoney Lonesome directly beneficially owned 3,504,347 Shares, constituting approximately 8.7% of the Shares outstanding. CCM, as the general partner of Stoney Lonesome, may be deemed the beneficial owner of the 3,504,347 Shares directly owned by Stoney Lonesome, constituting approximately 8.7% of the Shares outstanding. As of the date hereof, Drake Helix directly beneficially owned 83,000 Shares, constituting approximately 0.2% of the Shares outstanding. CDC Financial, as the managing member of each of CCM and Drake Helix, may be deemed the beneficial owner of the (i) 3,504,347 Shares directly owned by Stoney Lonesome and (ii) 83,000 Shares directly owned by Drake Helix, constituting approximately 8.9% of the Shares outstanding. As of the date hereof, Mr. Coghill directly beneficially owned 2,410 Shares, constituting approximately 0.01% of the Shares outstanding. Mr. Coghill, as the President and sole shareholder of CDC Financial, may also be deemed the beneficial owner of the (i) 3,504,347 Shares directly owned by Stoney Lonesome and (ii) 83,000 Shares directly owned by Drake Helix, which, together with the 2,410 Shares he directly owns, constitutes an aggregate of 3,589,757 Shares, constituting approximately 8.9% of the Shares outstanding. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.

Item 5(b) is hereby amended and restated to read as follows: Each of Stoney Lonesome, CCM, CDC Financial and Mr. Coghill may be deemed to share the power to vote and dispose of the Shares directly owned by Stoney Lonesome. Each of Drake Helix, CDC Financial and Mr. Coghill may be deemed to share the power to vote and dispose of the Shares directly owned by Drake Helix. Mr. Coghill has the sole power to vote and dispose of the Shares directly owned by him.

Item 5(c) is hereby amended and restated as follows: The transactions in securities of the Issuer by the Reporting Persons since the filing of Amendment No. 3 to the Schedule 13D are set forth in Exhibit 2 and are incorporated herein by reference. All of such transactions were effected in the open market unless otherwise noted therein.

Item 5(d) is hereby amended and restated to read as follows: No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.

Item 6 is hereby amended to add the following: On August 14, 2025, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference. On July 1, 2025, Mr. Coghill was awarded 41,922 restricted stock units ("RSUs") in connection with his service as a director of the Issuer. The RSUs, which convert into Shares on a one-for-one basis, vest on the first anniversary of the date of grant so long as Mr. Coghill remains a member of the board of directors of the Issuer through the vesting date.

Item 7 is hereby amended to add the following exhibits: 1 - Directors and Officers. 2 - Transactions in Securities. 99.1 - Joint Filing Agreement, dated August 14, 2025.